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Abstract
Background: In premature ovarian failure (POF), cessation of menstruation occurs before the expected age of menopause.
Approximately 1% of women are affected. FMR1 premutation was reported to be responsible for up to 3.3%–6.7% of
sporadic POF and 13% of familial cases in Caucasians, while the data was absent in Chinese population. Therefore, the
impact of FMR1 CGG repeat on ovarian reserve is needed to be investigated in large Chinese cohort.
Methods: The number of FMR1 CGG repeat was determined in 379 Han Chinese women with well-defined 46, XX non-
syndromic sporadic POF and 402 controls. The age of menopause onset in respect to CGG repeats was further analyzed.
Results: The frequency of FMR1 premutation in Han Chinese POF was only 0.5% (2/379), although it was higher than that in
matched controls (0%, 0/402), it was much lower than that reported in Caucasian with POF (3.3%–6.7%). The prevalence of
intermediate FMR1 (41–54) was not increased significantly in sporadic POF than that in controls (2.9% vs. 1.7%, P = 0.343).
However, POF patients more often carried a single additional CGG repeat in a single allele than did fertile women (allele-1:
29.7 vs. 28.8, P,0.001; allele-2: 32.6 vs. 31.5, P,0.001). POF patients with both alleles of CGG repeats outside (below or
above) the normal range (26–34) showed an earlier age of cessation of menses than those with two alleles within normal
range (hom-high/high vs. norm: 20.464.8 vs. 24.766.4, p,0.01; hom-low/high vs. norm: 18.761.7 vs. 24.766.4, p,0.01).
Conclusions: FMR1 premutation seems to be an uncommon explanation for POF in Han Chinese. However, having both
alleles with CGG repeats outside the normal range might still adversely affect ovarian aging.
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Introduction
Fragile X mental retardation 1 (FMR1) is an X-linked gene
carrying dynamic triplet CGG repeats in its 59 untranslated region
[1]. Alleles with #40 CGG repeats are traditionally considered
normal [2]. The full mutation, in which alleles have .200 CGG
repeats, causes transcriptional silence of FMR1 gene, absence of
the fragile X mental retardation protein (FMRP) and well
characterized features of the fragile X syndrome, which was the
most common cause of inherited mental retardation and autism
[3]. Between the normal (29–31) and full mutation (.200) range,
there are intermediate and premutation range, both unstable and
capable of expanding to full mutation over several generations [2].
The premutation range starts with 55 repeats and ends at 199
repeats; the intermediate range remains controversial, but
generally is considered 41 or 45 to 54 repeats [2,4].
FMR1 premutation (55–199) is accepted as a relatively common
explanation for altered ovarian function and loss of fertility [5]. In
mouse model carrying FMR1 premutation, reduced number of
growing follicles and impaired female fertility was observed and a
reduced phosphorylation of Akt and mTOR proteins was
elucidated [6]. In Caucasians, the prevalence of premature
ovarian failure (POF) in FMR1 premutation carriers is signifi-
cantly higher than that in general population (13%–26% vs. 1%)
[2]. FMR1 premutation occurs more frequently in POF patients
having a positive family history compared to sporadic ones (13%–
16% vs. 1.6%–3.0% in British; 12.1% vs.10% in Italian) [7–11].
However, in POF patients from Hong Kong (China) and Japan,
the frequency of FMR1 premutation was only 0.9% (1/116) and
1.6% (2/128), respectively [4,12]. Another two studies in Indian,
including 80 and 289 POF patients respectively, revealed none of
them carrying FMR1 premutation [13,14]. These data indicated
that fewer patients with POF from Asian than Caucasian carried
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FMR1 premutation. Barasoain et.al found intermediate FMR1
(35–54 CGG repeats) associated with diminished ovarian reserve
[15]. Gleicher and colleagues believe that having less than
intermediate (41–54) but greater than the accepted normal (29–
31) CGG repeats deleteriously affects ovarian ageing [16,17],
perhaps influencing the ovarian response [18] and adversely
affecting outcome during IVF-ET treatment [19]. In contrast,
Lledo [20], Bennett [21] and Murray [8] found that in Spanish
and British populations neither ovarian reserve nor ovarian
response was adversely affected by intermediate or normal high
sized CGG repeat. These contradictions led us to wonder how the
FMR1 mutations in Chinese women with POF, and furthermore
the clinical significance of FMR1 tests.
Materials and Methods
Study population
In this control cohort study, we investigated 379 sporadic POF
patients and 402 matched controls for the number of triple CGG
repeats in both alleles of FMR1 gene. Inclusion criteria for POF
consisted of cessation of menstrual cycles before 40 years of age,
with at least twice serum follicle stimulating hormone (FSH)
concentrations exceeding 40 IU/L. Women with known chromo-
somal abnormalities, previous ovarian surgery, chemotherapy,
radiotherapy or familial member diagnosed with POF were
excluded. Information was sought on associated somatic anoma-
lies, specifically adult onset neurologic disorder, referred to as
fragile X–associated tremor/ataxia syndrome, or mental retarda-
tion. The 402 controls were recruited from a cohort for health
checkup. They were known to be menstruating regularly, had
normal FSH levels and normal pelvic ultrasound imaging. Clinical
features of POF patients and controls were shown in Table 1.
Informed consents were signed by all subjects. This study was
approved by the Institutional Review Board of Reproductive
Medicine of Shandong University.
Genotype analysis
With the genomic DNA extracted from peripheral blood
lymphocytes, the FMR1 gene was amplified by PCR with
fluorescently labeled primers [1,22], and the CGG repeats of
two alleles were counted by capillary electrophoresis (CE) on an
ABI 3730 instrument (Applied Biosystems, Madrid, Spain). If only
one allele was identified, a rich CGG repeat primed (RP) PCR was
performed using AmplideX FMR1 PCR Kit (Asuragen, USA),
and the PCR products detected by CE were analyzed using Gene
Mapper 4.0 software (Applied Biosystems).
Referring to the nomenclature of Gleicher, et al., the allele with
lower number of CGG repeats was defined as allele-1, whereas the
one with a higher number was defined as allele-2 [16]. The normal
range was defined as 26–34 CGG repeats and the designations of
FMR1 genotypes under discussion here referred to the classifica-
tion rules raised by Gleicher, et al [23]: normal (norm)– both
alleles within normal range; heterozygous (het)– one allele within
normal range and the other one outside, further stratified as het-
norm/low and het-norm/high, according to the abnormal allele
being below or above normal range; homozygous (hom)– both
alleles outside normal range, further stratified as hom-low/low,
hom-high/high and hom-low/high according to the rules took above
(Table 2).
Statistical analysis
SPSS 19.0 computer software (IBM, Armonk, NY, USA) was
used for data analysis. The continuous data were checked for
normality and described as mean 6 SD or mean (95% confidence
interval for mean). Numerical data were analyzed by independent
sample T-tests or Mann-Whitney Test, and Pearson chi-square
test or Fisher’s exact test was used to test categorical data. All the P
values were two-sided, and P,0.05 was considered statistically
significant.
Results
Compared with controls, both allele-1 and allele-2 in POF cases
demonstrated a small but significant shift towards a single
additional CGG repeat (29.7 vs. 28.8, P,0.001; 32.6 vs. 31.5,
P,0.001, respectively) (Table 3). FMR1 premutation (55–199) was
observed in only two POF patients (2/379, 0.5%) and none of
normal matched controls. The prevalence of intermediate FMR1
(41–54) in POF cases was not increased significantly compared
with controls (2.9% vs. 1.7%, P= 0.343) (Table 3). POF patients
with sub-genotype hom-high/high and hom-low/high showed earlier
age at menopause compared with norm (20.464.8 vs. 24.766.4,
p,0.01; 18.761.7 vs. 24.766.4, p,0.01, respectively) (Figure 1).
Discussion
Investigating the largest POF cohort of Han Chinese females
accumulated to date, we initially determined the frequency of
FMR1 premutation to be only 0.5% (2/379), much lower than
that previously reported in Caucasian cohorts: British (1.6–3%)
[7,8,10], Italian (3.3–10%) [9,11], Polish (7.9%) [24], Turkish
(4.9%) [25] and Slovenian samples (4.8%) [26]. The premutation
frequency was 1.6% in the only reported Japanese study [4], and
Table 1. Clinical characteristics of POF patients and controls.
Characteristics POF Control
,40 yrs 40–44 yrs
No. 379 378 24
Age (yrs) 31.764.2 30.564.4 41.161.4
Age at menarche (yrs) 14.561.8 14.961.5 15.261.5
Age at onset of menstrual dysfunction (yrs) 23.366.5 - -
Age of amenorrhea (yrs) 25.165.6 - -
Age at diagnosis (yrs) 30.164.8 - -
FSH (IU/L) 77.0627.4 7.461.8 8.262.6
Note: All of the normal control women did not have amenorrhea.
doi:10.1371/journal.pone.0103316.t001
FMR1 Expansion in Han Chinese POF
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0.9% in the smaller Chinese study [12]. Therefore, FMR1
premutation seems to be an uncommon explanation for POF in
Han Chinese. Furthermore, there was no significant difference
with respect to intermediate FMR1 between POF cases and
controls (2.9% vs. 1.7%, P= 0.343). Similar prevalence has been
drawn from Japanese POI cohorts (3.9%) [4], indicating that
intermediate FMR1 does not contribute to POF in Chinese either
[8,21]. However, in some Caucasian studies the effect of
intermediate FMR1 on ovarian function was controversial.
Barasoain and Gleicher et al. found normal high sized and
intermediate FMR1 (35–54 CGG repeats) associated with
diminished ovarian reserve [15]. In contrast, Lledo [20], Bennett
[21] and Murray [8] found that in Spanish and British populations
neither ovarian reserve nor ovarian response was adversely
affected by intermediate or normal high sized CGG repeat. The
Table 2. Distribution of FMR1 genotype and sub-genotype in sporadic POF patients.
Allele-1 Allele-2 POF (n=379)
norm 26–34 26–34 256 (67.5%)
het het-norm/low ,26 26–34 20 (5.3%)
het-norm/high 26–34 .34 90 (23.7%)
Total 110 (29.0%)
hom hom-low/low ,26 ,26 1 (0.3%)
hom-high/high .34 .34 9 (2.4%)
hom-low/high ,26 .34 3 (0.8%)
Total 13 (3.5%)
Note: By definition allele 1 has the lowest number of repeats. norm: both alleles within normal range; het: one allele within normal range and the other allele outside;
hom: both alleles outside normal range.
doi:10.1371/journal.pone.0103316.t002
Figure 1. POF patients with sub-genotype hom-high/high and hom-low/high showed earlier age at menopause compared with norm
(20.4±4.8 vs. 24.7±6.4, p,0.01; 18.7±1.7 vs. 24.7±6.4, p,0.01, respectively).
doi:10.1371/journal.pone.0103316.g001
FMR1 Expansion in Han Chinese POF
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contradiction might be attributed to ethnic differences and the bias
of recruited participators in each study.
In our study, the distribution of FMR1 genotypes in sporadic
POF patients was similar to that previously reported in Asian
cohort [27]. POF patients with sub-genotype hom-high/high and
hom-low/high showed an earlier age of onset of menopause
compared with those with norm (20.464.8 vs. 24.766.4, p,0.01;
18.761.7 vs. 24.766.4, p,0.01, respectively) (Figure 1). That
consist with Gleicher’s conclusion [19,28], which suggested that
not only abnormally higher CGG repeat numbers have deleterious
effect on ovarian aging but also abnormally lower numbers. Our
results indicated that having both alleles, rather than a single allele,
with CGG repeats outside (above or below) the normal range
might adversely affects ovarian function and presumably ovarian
reserve in Han Chinese. Considering the relatively small sample
size of the sub-genotype hom-high/high (n=9) and hom-low/high
(n=3), more studies with larger sample size are needed.
The seemingly contradictory findings of a low sporadic FMR1
premutation carrier rate (0.5%) and no increased prevalence of
intermediate FMR1 in Han Chinese POF, the deleterious effect of
a single additional CGG repeat are not well explained. However in
other dynamic mutations (e.g. Huntington disease, myotonic
dystrophy, spino-bulbar muscular atrophy), the number of
amplified repeats needed to exert a phenotypic effect is not much
larger than that considered normal. For example, in Huntington
disease, deleterious effects are manifested with more than 36 CAG
repeats, whereas 8–35 repeats is normal [29]. In myotonic
dystrophy type 1, .50 CTG repeats is abnormal, while 5–37
repeats normal [30]. In spino-bulbar muscular atrophy,.40 CAG
repeats is abnormal, but 14–32 repeats normal [31]. In Fragile X
syndrome the wide dichotomy between modal number of CGG
repeats (29–31) and the .200 required for mental retardation is
the exception. By contrast, considering POF cases having CGG
repeats outside normal but below intermediate range showed
relatively earlier age at menopause, ovarian disturbance may be
sensitive to small changes in CGG repeats, more analogous to
observations in Huntington disease and myotonic dystrophy type 1.
In summary, FMR1 premutation was not a common explana-
tion for sporadic POF in Han Chinese. But in some familial POF
patients, male or female relative with mental retardation could be
observed; thus, POF or fragile X tremor/ataxia syndrome could
arise in the next generation of familial POF patients. Therefore,
from a clinical perspective our results do not obviate the need for
FMR1 testing in a woman having POF, even Chinese. Yet, pause
may be in order before embarking on general population
screening programs in Chinese or Asian populations in the
absence of a positive family history.
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